These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 18423121

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles.
    Alhareth K, Vauthier C, Gueutin C, Ponchel G, Moussa F.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar 01; 887-888():128-32. PubMed ID: 22341684
    [Abstract] [Full Text] [Related]

  • 23. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
    Fu L, Liang Y, Deng L, Ding Y, Chen L, Ye Y, Yang X, Pan Q.
    Cancer Chemother Pharmacol; 2004 Apr 01; 53(4):349-56. PubMed ID: 14666379
    [Abstract] [Full Text] [Related]

  • 24. Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.
    Trail PA, Willner D, Knipe J, Henderson AJ, Lasch SJ, Zoeckler ME, TrailSmith MD, Doyle TW, King HD, Casazza AM, Braslawsky GR, Brown J, Hofstead SJ, Greenfield RS, Firestone RA, Mosure K, Kadow KF, Yang MB, Hellström KE, Hellström I.
    Cancer Res; 1997 Jan 01; 57(1):100-5. PubMed ID: 8988048
    [Abstract] [Full Text] [Related]

  • 25. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V, Grazeliene G, Dabkeviciene D, Micke I, Kirvelis D, Juodka B, Didziapetriene J.
    Cancer Chemother Pharmacol; 2006 Jan 01; 57(1):65-72. PubMed ID: 16001168
    [Abstract] [Full Text] [Related]

  • 26. In vitro and in vivo activities of a doxorubicin prodrug in combination with monoclonal antibody beta-lactamase conjugates.
    Svensson HP, Vrudhula VM, Emswiler JE, MacMaster JF, Cosand WL, Senter PD, Wallace PM.
    Cancer Res; 1995 Jun 01; 55(11):2357-65. PubMed ID: 7757987
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Improved HPLC method for doxorubicin quantification in rat plasma to study the pharmacokinetics of micelle-encapsulated and liposome-encapsulated doxorubicin formulations.
    Wei G, Xiao S, Si D, Liu C.
    Biomed Chromatogr; 2008 Nov 01; 22(11):1252-8. PubMed ID: 18651589
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy of different immunotherapy approaches toward treatment of doxorubicin-resistant and doxorubicin-sensitive transplantable rhabdomyosarcoma.
    Belova OB, Vinnichuk UD, Shlakhovenko VA, Berezhnaya NM.
    Exp Oncol; 2007 Dec 01; 29(4):272-6. PubMed ID: 18199982
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C, Wellham LL.
    Anticancer Res; 2003 Dec 01; 23(3B):2681-90. PubMed ID: 12894558
    [Abstract] [Full Text] [Related]

  • 34. CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors.
    Pan C, Cardarelli PM, Nieder MH, Pickford LB, Gangwar S, King DJ, Yarranton GT, Buckman D, Roscoe W, Zhou F, Salles A, Chen TH, Horgan K, Wang YH, Nguyen T, Bebbington CR.
    Cancer Res; 2003 Sep 01; 63(17):5526-31. PubMed ID: 14500390
    [Abstract] [Full Text] [Related]

  • 35. Extensive intracellular accumulation of ID-6105, a novel anthracycline, in SK-OV-3 ovarian cancer cells.
    Shin DH, Choi KS, Park SA, Cho BS, Lee HS, Ryu JS, Kim TY, Lee CK, Song S, Chung YB.
    Arch Pharm Res; 2008 Oct 01; 31(10):1355-61. PubMed ID: 18958428
    [Abstract] [Full Text] [Related]

  • 36. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
    Hu FQ, Liu LN, Du YZ, Yuan H.
    Biomaterials; 2009 Dec 01; 30(36):6955-63. PubMed ID: 19782395
    [Abstract] [Full Text] [Related]

  • 37. [Determination of ethmozine in human plasma by high performance liquid chromatography and its pharmacokinetics].
    Tan L, Xia YB, Tu XD, Yuan YS.
    Yao Xue Xue Bao; 1994 Dec 01; 29(3):232-6. PubMed ID: 8079651
    [Abstract] [Full Text] [Related]

  • 38. Determination of desoxyepothilone B in nude mice plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography.
    Wang Z, Wang H, Rhie JK, Covey JM, Liang P, Wang S, Wang C, Hu Y, Prasad G, Nan L, Hill DL, Zhang R.
    J Pharm Biomed Anal; 2006 Sep 18; 42(2):272-6. PubMed ID: 16616824
    [Abstract] [Full Text] [Related]

  • 39. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects.
    Ponce AM, Viglianti BL, Yu D, Yarmolenko PS, Michelich CR, Woo J, Bally MB, Dewhirst MW.
    J Natl Cancer Inst; 2007 Jan 03; 99(1):53-63. PubMed ID: 17202113
    [Abstract] [Full Text] [Related]

  • 40. Determination of endothelin antagonist BMS182874 in plasma by high-performance liquid chromatography.
    Chavanpatil MD, Rajeshkumar NV, Gulati A.
    Pharmazie; 2006 Jun 03; 61(6):525-7. PubMed ID: 16826972
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.